Search

everythinglearnresearchcommunity

for

Search:↓

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Minoxidil improved rat skin flap survival but was less effective than surgical methods.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Targeted cancer therapies often cause serious skin problems that need careful management.

New effective scar treatments are urgently needed due to the current options' limited success.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The document concludes that a better understanding of cell changes during wound healing could improve treatments for chronic wounds and other conditions.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Lowering testosterone speeds up wound healing in male mice.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Iranian veterans exposed to sulfur mustard suffer from long-term skin itching and eye damage, with some risk of skin cancer and ongoing management challenges.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Testosterone may slow down wound healing and increase inflammation.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.